Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

JA Roberts, MH Abdul-Aziz, J Lipman… - The Lancet infectious …, 2014 - thelancet.com
Infections in critically ill patients are associated with persistently poor clinical outcomes.
These patients have severely altered and variable antibiotic pharmacokinetics and are …

Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

A guide to therapeutic drug monitoring of β‐lactam antibiotics

AJ Fratoni, DP Nicolau, JL Kuti - Pharmacotherapy: The Journal …, 2021 - Wiley Online Library
Therapeutic drug monitoring (TDM) opens the door to personalized medicine, yet it is
infrequently applied to β‐lactam antibiotics, one of the most commonly prescribed drug …

Clinical implications of antibiotic pharmacokinetic principles in the critically ill

AA Udy, JA Roberts, J Lipman - Intensive care medicine, 2013 - Springer
Successful antibiotic therapy in the critically ill requires sufficient drug concentrations at the
site of infection that kill or suppress bacterial growth. The relationship between antibiotic …

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia

MH Kollef, J Chastre, M Clavel, MI Restrepo, B Michiels… - Critical Care, 2012 - Springer
Introduction The aim of this study was to compare a 7-day course of doripenem to a 10-day
course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram …

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

JJ De Waele, J Lipman, M Akova, M Bassetti… - Intensive care …, 2014 - Springer
Purpose Risk factors for β-lactam antibiotic underdosing in critically ill patients have not
been described in large-scale studies. The objective of this study was to describe …

Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France

B Lefèvre, L Tondeur, Y Madec, R Grant… - The Lancet Healthy …, 2021 - thelancet.com
Variants of SARS-CoV-2 have emerged that are more transmissible than the original virus or
that exhibit some properties of immune escape, or both. The beta (B. 1.351) variant has …

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …

Optimizing antimicrobial drug dosing in critically ill patients

P Póvoa, P Moniz, JG Pereira, L Coelho - Microorganisms, 2021 - mdpi.com
A fundamental step in the successful management of sepsis and septic shock is early
empiric antimicrobial therapy. However, for this to be effective, several decisions must be …

What are the current approaches to optimising antimicrobial dosing in the intensive care unit?

MG Chai, MO Cotta, MH Abdul-Aziz, JA Roberts - Pharmaceutics, 2020 - mdpi.com
Antimicrobial dosing in the intensive care unit (ICU) can be problematic due to various
challenges including unique physiological changes observed in critically ill patients and the …